Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,93 USD | -5,60% | -15,19% | +12,19% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 992 mln. 925 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -195 mln. -182 mln. | Nettowinst (verlies) 2025 * | -209 mln. -195 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 92,93 mln. 86,62 mln. | Nettoliquiditeiten 2025 * | 93,52 mln. 87,16 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,91
x | K/w-verhouding 2025 * |
-5,15
x | Werknemers | 76 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,4% |
Recentste transcriptie over Centessa Pharmaceuticals plc
1 dag | -5,60% | ||
1 week | -15,19% | ||
Lopende maand | -20,97% | ||
1 maand | -22,42% | ||
3 maanden | +14,05% | ||
6 maanden | +43,11% | ||
Lopend jaar | +12,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01-01-21 |
Director of Finance/CFO | 53 | 01-03-21 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 03-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 61 | 23-02-21 | |
Chairman | 54 | 01-11-20 | |
Brett Zbar
BRD | Director/Board Member | 51 | 01-01-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 8,93 | -5,60% | 286 596 |
24-04-24 | 9,46 | +0,64% | 2 251 501 |
23-04-24 | 9,4 | -6,00% | 200 077 |
22-04-24 | 10 | -5,39% | 210 810 |
19-04-24 | 10,57 | +0,38% | 163 006 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,19% | 992 mln. | |
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+47,53% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |